The CatSper-Test: from bench to bedside
Join us on April 18th to hear the story about the start-up enterprise Truion GmbH which is based in Münster, Germany. Their journey promises to offer illuminating perspectives on the fusion of scientific innovation with business ventures.
Thursday, April 18th 2024
16:00 CEST
Vincent Lucas Fischer (CEO) and Dr. rer. nat. Samuel Young (Bioengineer) will share with us the story behind Truion GmbH, the company they found to develop ‘CatFlux’, a novel CatSper-Test to enable healthcare professionals to offer personalized treatment solutions to infertile patients.
From left to right: Vincent Lucas Fischer, Christian Schiffer, and Samuel Young